RSS   Newsletter   Contact   Advertise with us
Post Online Media

Eli Lilly and Co. adds Carolyn R. Bertozzi to board

Carolyn R BertozziEli Lilly and Company, a pharmaceutical company, announced that it has elected Carolyn R. Bertozzi as a new member of the board of directors.

Ms. Bertozzi will serve on the Science and Technology and Public Policy and Compliance Committees of the board.

Article continues below

READ MORE Eli Lilly and Co. CEO John C. Lechleiter to take medical leave

Ms. Bertozzi is the Anne T. and Robert M. Bass Professor of Chemistry and Professor of Chemical & Systems Biology and Radiology at Stanford University, and an Investigator of the Howard Hughes Medical Institute.

Ms. Bertozzi completed her undergraduate degree in chemistry from Harvard University in 1988 and her doctorate in chemistry from UC Berkeley in 1993.

After completing postdoctoral work at UCSF in the field of cellular immunology, Ms. Bertozzi joined the UC Berkeley faculty in 1996.

In June 2015, she joined the faculty at Stanford University coincident with the launch of Stanford's ChEM-H institute.

What to read next


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy